Aggressive variants of prostate cancer: underlying mechanisms of neuroendocrine transdifferentiation

Abstract Prostate cancer is a hormone-driven disease and its tumor cell growth highly relies on increased androgen receptor (AR) signaling. Therefore, targeted therapy directed against androgen synthesis or AR activation is broadly used and continually improved. However, a subset of patients eventua...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Lina Merkens, Verena Sailer, Davor Lessel, Ella Janzen, Sarah Greimeier, Jutta Kirfel, Sven Perner, Klaus Pantel, Stefan Werner, Gunhild von Amsberg
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2022-02-01
coleção:	Journal of Experimental & Clinical Cancer Research
Assuntos:	Aggressive variant prostate cancer Small cell prostate cancer Neuroendocrine prostate cancer Neuroendocrine transdifferentiation
Acesso em linha:	https://doi.org/10.1186/s13046-022-02255-y
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!